While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth ...

London stocks were still a touch higher by midday on Wednesday as investors continued to mull the impact of Trump’s trade war ...

GSK shares surge as the drugmaker raises its 2031 sales target to over £40bn, boosts dividends, and announces a £2bn share buyback plan.

ViiV Healthcare has secured European Commission approval for its long-acting HIV treatment, Vocabria + Rekambys, for adolescents aged 12 and olde ...

Takeda CEO Christophe Weber announced he will step down in 2026 and be replaced by Julie Kim, president of Takeda’s U.S.

Julie Kim, currently Takeda’s U.S. head, will replace Weber in June 2026 and become one of the few female CEOs of a top ...

Appasamy Associates has appointed Annaswamy Vaidheesh as its non-executive chairman. With over 35 years of experience in the ...

GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme.

In its first financial results since its insurance unit CEO was fatally shot in New York City, UnitedHealth Group reported Thursday weaker-than-expected fourth-quarter revenue, prompting its ...

TikTok CEO Shou Zi Chew plans to attend President-elect Donald Trump's inauguration on Monday as the company confronts a new law with a looming deadline requiring it to sell to a non-Chinese firm ...

TikTok CEO Shou Zi Chew will attend President-elect Trump’s inauguration Monday, one day after a potential ban of the video sharing platform could take effect in the U.S., according to a source ...

who ran the big drugmaker GlaxoSmithKline for nearly a decade before joining UnitedHealth Group’s management team to run Optum before being elevated to CEO of UnitedHealth. “OptumRx alone ...